Alfred D Kingsley - Net Worth and Insider Trading
Alfred D Kingsley Net Worth
The estimated net worth of Alfred D Kingsley is at least $4 Million dollars as of 2025-04-28. Alfred D Kingsley is the See Remarks of Lineage Cell Therapeutics Inc and owns about 7,300,252 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $4 Million. Alfred D Kingsley is the Director of OncoCyte Corp and owns about 28,161 shares of OncoCyte Corp (OCX) stock worth over $96,874. Alfred D Kingsley is also the Director of Asterias Biotherapeutics Inc and owns about 9,000 shares of Asterias Biotherapeutics Inc (AST) stock worth over $8,505. Details can be seen in Alfred D Kingsley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alfred D Kingsley has not made any transactions after 2023-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alfred D Kingsley
Alfred D Kingsley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alfred D Kingsley owns 3 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , OncoCyte Corp (OCX) , and Asterias Biotherapeutics Inc (AST) .
Click here to see the complete history of Alfred D Kingsley’s form 4 insider trades.
Insider Ownership Summary of Alfred D Kingsley
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2017-07-31 | other: 13D Group-10% Owner |
| OCX | OncoCyte Corp | 2023-06-14 | director |
| AST | Asterias Biotherapeutics Inc | 2016-06-09 | director |
Alfred D Kingsley Latest Holdings Summary
Alfred D Kingsley currently owns a total of 3 stocks. Among these stocks, Alfred D Kingsley owns 7,300,252 shares of Lineage Cell Therapeutics Inc (LCTX) as of July 31, 2017, with a value of $4 Million and a weighting of 97.14%. Alfred D Kingsley owns 28,161 shares of OncoCyte Corp (OCX) as of June 14, 2023, with a value of $96,874 and a weighting of 2.63%. Alfred D Kingsley also owns 9,000 shares of Asterias Biotherapeutics Inc (AST) as of June 9, 2016, with a value of $8,505 and a weighting of 0.23%.
Latest Holdings of Alfred D Kingsley
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2017-07-31 | 7,300,252 | 0.49 | 3,577,123 |
| OCX | OncoCyte Corp | 2023-06-14 | 28,161 | 3.44 | 96,874 |
| AST | Asterias Biotherapeutics Inc | 2016-06-09 | 9,000 | 0.95 | 8,505 |
Holding Weightings of Alfred D Kingsley
Alfred D Kingsley Form 4 Trading Tracker
According to the SEC Form 4 filings, Alfred D Kingsley has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the sale of 150,000 shares on July 31, 2017, which brought Alfred D Kingsley around $420,000.
According to the SEC Form 4 filings, Alfred D Kingsley has made a total of 5 transactions in OncoCyte Corp (OCX) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in OncoCyte Corp is the acquisition of 1,500 shares on June 14, 2023, which cost Alfred D Kingsley around $6,300.
According to the SEC Form 4 filings, Alfred D Kingsley has made a total of 0 transactions in Asterias Biotherapeutics Inc (AST) over the past 5 years. The most-recent trade in Asterias Biotherapeutics Inc is the acquisition of 4,000 shares on June 9, 2016, which cost Alfred D Kingsley around $11,720.
Insider Trading History of Alfred D Kingsley
- 1
Alfred D Kingsley Trading Performance
GuruFocus tracks the stock performance after each of Alfred D Kingsley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alfred D Kingsley is -12.21%. GuruFocus also compares Alfred D Kingsley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alfred D Kingsley within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alfred D Kingsley's insider trading performs compared to the benchmark.
Performance of Alfred D Kingsley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.98 | | | | | |
| Relative Return to S&P 500(%) | 10.51 | | | | | |
Alfred D Kingsley Ownership Network
Ownership Network List of Alfred D Kingsley
Ownership Network Relation of Alfred D Kingsley
Alfred D Kingsley Owned Company Details
What does Lineage Cell Therapeutics Inc do?
Who are the key executives at Lineage Cell Therapeutics Inc?
Alfred D Kingsley is the other: 13D Group-10% Owner of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include 10 percent owner Broadwood Partners Lp , Chief Financial Officer Jill Ann Howe , and General Counsel/Secretary Samuel George A. Iii .
Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary
Over the past 18 months, Alfred D Kingsley made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 14,625,507 shares made by Broadwood Partners Lp , a net purchase of 50,000 shares made by Brian M Culley , and a net purchase of 25,500 shares made by Jill Ann Howe .
In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 14,862,162 shares were bought by its insiders, resulting in a net purchase of 14,862,162 shares.
Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lineage Cell Therapeutics Inc Insider Transactions
Alfred D Kingsley Mailing Address
Above is the net worth, insider trading, and ownership report for Alfred D Kingsley. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Alfred D Kingsley's mailing address is: New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
